 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Date of | Nature of | No. of Nature of | Face | Cost/ Reason for | Cumulative | Cumulati
Acquisiti | Transacti | Equity | Considerati | value | transfer | allotment/ amount | ve no. of
on on Shares on ofthe} price transfer paid for the) Equity
/Transfer Equit| per (preferential Equity Shares*
. y Equity | allotment/bon| Shares
Share| Share us etc.)
s_ | (includin
@®] sg.
securitie
s
premiu
m) @
April 10,| Allotment | 100 Cash 10.00] 66,295.0} Further issue 6,629,509 100
2019 9
December | Purchase | 21,233 Cash 10.00) 76,765.0 NA| 1,636,580,7 21,333
27, 2019 0 54
January Equity 26,666 NA 10.00 - NA} 1,636,580,7 47,999
22,2021 | Bonus 54
July 9, | Split of }2,39,995 |NA 2.00 - NA| 1,636,580,7] 2,39,995
2021 Equity 54
Shares
November | Conversio | 1,41,82,1 | Consideratio 2.00 143.73 NA| 3,674,956,1| 14,422,10
22,2021 |n of Series| 05 n_ paid for 93 0
A CCPS to CCPS
Equity
November | Conversio |95,99,800 |NA 2.00 - NA| 3,674,956,1| 24,021,90
22,2021 |n of Series 93 0
B CCPS to
Equity
November | Conversio |6,39,485 | Consideratio 2.00 347.32 NA| 3,897,060,8| 24,661,38
22,2021 |n of Series n_ paid for 64 5
C2 CCPS CCPS
to Equity
Weighted average price of acquisition per Equity Share 158.02
SS Pharma
Date of | Nature of | No.of | Natureof | Face | Cost/ Reason for | Cumulativ | Cumulativ
Acquisitio | Transactio | Equity | Consideratio | value | transfer | allotment/ | e amount | eno. of
n n Shares n of the | price per transfer paid for Equity
/Transfer” Equit | Equity | (preferential | the Equity] Shares
y Share | allotment/bon | Shares
Share | (includin us etc.)
s g
@)_| securitie
s
premium
)@)
December | Purchase 4,012 Cash 10.00} 76,765.0 NA| 307,981,18 4,012
27, 2019 0 0
January Equity 5,015 NA 10.00 - NA| 307,981,18 9,027
22, 2021 Bonus 0
July 9, | Split of/45,135  |NA 2.00 - NA| 307,981,18 45,135
2021 Equity 0
Shares
November | Conversion | 18,05,40 | NA. 2.00 - NA| 307,981,18| 1,850,535,
22,2021 |of CCPS to|0 0
Equit
Weighted average price of acquisition per Equity Share 166.43

 

 

 

 

Shore Pharma

86

 

 
